THERAPEUTIC SURROGATE END POINT FOR ANTI-CTLA-4 BASED IMMUNTERAPY OF DISEASE
- 专利权人:
- E. R. Squibb & Sons; L.L.C.
- 发明人:
- LOWY, Israel,NICHOL, Geoffrey, M.
- 申请号：
- DK04785793
- 公开号：
- DK1639010T3
- 申请日:
- 2004.05.28
- 申请国别(地区):
- DK
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention provides a method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.
- 来源网站：
- 中国工程科技知识中心
